Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus

Journal of the Chinese Medical Association

Volumn 70, Issue 2, 2007, Pages 65-70

  Huang, Cheng Hung ^a   Chen, Chih Chiang ^a   Wang, Chi Jui ^a   Chang, Yun Ting ^a   Liu, Han Nan ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Desmoglein 1; Desmoglein 3; Enzyme linked immunosorbent assay; Pemphigus foliaceus; Pemphigus vulgaris

Indexed keywords

DESMOGLEIN 1; DESMOGLEIN 3; PROTEIN ANTIBODY;

ADULT; ARTICLE; BULLOUS PEMPHIGOID; CONTROLLED STUDY; DERMATITIS HERPETIFORMIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; REFERENCE VALUE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TAIWAN;

EID: 33847755822     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70304-1     Document Type: Article

References (25)

1. Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's Dermatology in General Medicine, 6th edition. New York: McGraw-Hill, 2003:558-67.
2. Hashimoto T, Ogawa MM, Konohana A, Nishikawa T. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol 1990;94:327-31.
3. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991;67:869-77.
4. Amagai M, Hashimoto T, Shimizu N, Nishikawa T. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 1994;94:59-67.
5. Koulu L, Kusumi A, Steinberg MS, Klaus-Kovttin V, Stanley JR Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med 1984;160:1509-18.
6. Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 1995;104:895-901.
7. Amagai M, Komai A, Hashimoto T, Shirakata Y, Hashimoto K, Yamada T, Kitajima Y, et al. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 1999;140:351-7.
8. Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S, Shimizu N, et al. Characterization of autoantibodies in pemphigus using antigen-specific ELISAs with baculovirus-expressed recombinant desmogleins. J Immunol 1997;159: 2010-7.
9. Lenz P, Amagai M, Volc-Platzer B, Stingl G, Kirnbauer R. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool. Arch Dermatol 1999;135:143-8.
10. Nishikawa T. Desmoglein ELISAs: a novel diagnostic tool for pemphigus. Arch Dermatol 1999;135:195-6.
11. Hahn K, Kippes W, Amagai M, Rzany B, Broker EB, Zillikens D. Clinical and immunopathological findings in 48 patients with pemphigus. Hautarzt 2000;51:670-7.
12. Harman K, Gratian M, Seed P, Bhogal B, Challacombe S, Black M. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol 2000;25:236-40.
13. Cheng SW, Kobayashi M, Tanikawa A, Kinoshita-Kuroda K, Amagai M, Nishikawa T. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol 2002;147:261-5.
14. Aoyama Y, Tsujimura Y, Funabashi M, Sato M, Kamiya H, Kirajima Y. An experience for ELISA for desmoglein 1, suggesting a possible diagnostic help to determine the initial therapy for pemphigus foliaceus. Eur J Dermatol 2000;10:18-21.
15. Yano C, Ishiji T, Kamide R, Niimura M. A case of pemphigus vulgaris successfully treated with single filtration plasmapheresis: a correlation of clinical disease activity with serum antibody levels. J Dermatol 2000;27:380-5.
16. Krain LS. Pemphigus: epidemiologic and survival characteristics of 59 patients, 1955-1973. Arch Dermatol 2000;110:862-5.
17. Pisanti S, Sharav Y, Kaufman E, Posner LN. Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med O 1974;38:382-7.
18. Hietanen J, Salo OP. Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978. Acta Derm Venereol (Stockh) 1982;62:491-6.
19. Bastuji-Garin S, Souissi R, Blum L, Turki H, Nouira R, Joman B, Zahaf A, et al. Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol 1995;104:302-5.
20. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999;103:461-8.
21. Wu H, Wang ZH, Yan A, Lyle S, Fakharzadeh S, Wahl JK, Wheelock MJ, et al. Protection against pemphigus foliaceus by desmoglein 3 in neonates. N Engl J Med 2000;343:31-5.
22. Ding X, Aoki V, Mascaro JM Jr, Lopez-Swiderski A, Diaz LA, Fairley JA. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol 1997;109:592-6.
23. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999;40:167-70.
24. Harman KE, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype. Br J Dermatol 2000;143:343-8.
25. Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001;144:775-80.